Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)
This study has been completed.
Information provided by:
First received: March 31, 2008
Last updated: April 2, 2008
Last verified: March 2008
This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.
Infection, Mycobacterium Avium-Intracellulare
|Official Title:||IND for One Patient to Receive Clofazamine for Treatment of MAI|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Yale University:
|Study Start Date:||May 2006|
|Study Completion Date:||May 2007|
|Primary Completion Date:||May 2007 (Final data collection date for primary outcome measure)|
Only one patient is being treated under a single patient IND.
Contacts and Locations